Abstract
BUSINESS Business Roundup ShareShare onFacebookTwitterWechatLinked InRedditEmail C&EN, 2023, 101 (8), p 13March 6, 2023Cite this:C&EN 101, 8, 13AbstractHuntsman has completed the sale of its textile effects business to Archroma for $593 million, plus assumed pension liabilities. Huntsman bought the business in 2006 from Ciba Specialty Chemicals. Albemarle is increasing its stake in an Australian lithium processing plant it’s building with Mineral Resources. In exchange, Mineral Resources is boosting its interest in an associated lithium mine the companies operate. Evonik Industries says it plans to spend a “mid-double-digit million” euro amount to build a fumed aluminum oxide plant in Yokkaichi, Japan. The company says aluminum oxide is used to make ultrathin separator coatings for lithium-ion batteries. Genascence , a firm targeting musculoskeletal diseases with gene therapy, has been awarded $11.6 million over 4 years by the California Institute for Regenerative Medicine. The money will go toward the company’s Phase 1b clinical trial of its lead gene therapy for knee osteoarthritis and to “phase-appropriate manufacturing activities.” Umicore saysView: PDF | Full Text HTML
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
